Home (in Vivo)
PRINT ISSN: 0258-851X
ONLINE ISSN: 1791-7549
During the current pandemic, efficient sharing of information is extremely important. For this reason, all articles for the Covid-19 Special Issue will be uploaded here ahead of print as soon as they have been peer-reviewed. The issue will be formally published in June 2020 and will be accessible on In Vivo’s website through Highwire Press.
CALL FOR PAPERS
IN VIVO Special Issue On SARS-Cov-2 and Covid-19 Disease
TOPICS: Reviews, experimental and clinical articles on all aspects of SARS-Cov-2 and Covid-19 disease.
Deadline for article submission: 18 May 2020
Publication Policy: Submitted articles should not exceed 20 typewritten pages plus figures and tables.
- All submitted manuscripts will be rapidly peer-reviewed within 3-5 days, and Authors will be immediately noticed if a revision is requested. Revised manuscripts should reach our office within 24-48 hours. Prompt arrangements focus on the rapid publication of this issue online OPEN ACCESS in the Highwire-IN VIVO site on June 2, 2020.
- All accepted papers will be subject to a publication fee of US$ 250.00. Color figures will be published free of charge.
- Manuscripts should follow our Instructions to Authors and should be submitted electronically (www.iiar-submissions.com).
Information: Dr. George J. Delinasios, e-mail: email@example.com
In Vivo is an international journal designed to bring together original high quality works and reviews on experimental and clinical biomedical research within the frames of human physiology, pathology and disease management. IN VIVO was established in 1987 by J.G. Delinasios. In this site you may find information concerning the editorial board, editorial policy, submission of manuscripts, contents of previous volumes and a current list of accepted manuscripts.
Impact factor (2019): 1.609
Total articles: 234
Total cites: 2,875
Now the entire contents of In Vivo published from 2013 till today
can be accessed for free from Android, iPhone, iPad and compatible Chromebook devices.
ANTICANCER RESEARCH USA, Inc.
111 Bay Avenue, Highlands, NJ 07732, USA.
Information – Editorial & Production Office:
Managing Editor: G. J. Delinasios, International Institute of Anticancer Research,
1st km Kapandritiou- Kalamou Rd., P.O.Box 22, Kapandriti, Attiki 19014, Greece.
Tel & Fax : +30-22950-52945, +30-22950-53389